“Zero to One” is a concept coined by Peter Thiel (PayPal, Palantir, Founders Fund).  It denotes a company which not only identifies a new and large market, but also develops the ability to capture a good deal of that market’s value.

The image to the left is a large expanse of sand with a small pocket of oil bubbling to the surface.  From those two simple ingredients the petrochemical and semiconductor industries evolved.  However, it was not enough to recognize the value of sand and viscous crude oil.  It was also necessary to build the infrastructure and processes necessary to capture that value.

RegenMed was founded — and operates — on the premise that real world data is to healthcare what sand was to semiconductors or crude to refined petrochemicals.  It is the commonplace — but uncaptured and unrefined raw materials — from which the most valuable healthcare innovations will emerge.

The high-quality datasets which can be generated from real world data are of immense value to healthcare insurers, providers, product manufacturers, and of course patients.  Physicians — closely collaborating with each other — are the key to identifying the most promised real-world data, capturing it, and helping unlock its value.  RegenMed’s clients prove this every day.

Healthcare in the U.S. is broken.  There are a few more important problems for us to solve.  The key is enabling and incentivizing physicians to generate the evidence based on real-world treatments and correlated patient outcomes.  RegenMed has built the patented platforms and processes which do that on a regular basis.

We and our clients welcome your investment so that we can rapidly expand upon this early zero to one success.  The opportunities are enormous.